News

AlivaMab Discovery Services Announces Multi-Target Agreement with Janssen

READ MORE

AlivaMab Discovery Services Identifies Highly Potent Antibodies in Two Months for Inaugural Client Project

READ MORE

Webinars

Begin with the End in Mind:

Selection of an Antibody Discovery Platform

How the choice of therapeutic antibody discovery platform can impact downstream success in development and the market.

WATCH

2019 Conferences

PEGS Europe

November 18 - 22, 2019
Lisbon, Portugal

Antibody Engineering & Therapeutics

December 9 - 13, 2019
San Diego, California

JP Morgan Healthcare Conference

January 13 - 16, 2020
San Francisco, California

Corporate Fact Sheet

DOWNLOAD

Interviews

Nature speaks to Larry Green, CEO

Harnessing platform technology and expertise to fuel antibody drug discovery

DOWNLOAD

Pharmaceutical Executive speaks with Larry Green

From Mouse to Mab

READ